COVID-19 Antiviral Pills, or those that patients would take to help them recover from the virus, are now the center of controversies as companies behind them ask for more significant payments for the drug. There are two COVID-19 pills on the market now, and they are from Merck and Pfizer, which developed them to heal from viral infection.
COVID-19 Antiviral Pills Ask for More Payment: More Expensive Now?
According to a report by the Wall Street Journal, the COVID-19 pills that the government bought from the private firms and companies have left them to name their prices. It means that these private firms can up the fees they ask from the government and not be regulated as much as when the contract controls their prices.
It can mean that the COVID-19 pills and their manufacturers or companies may ask for more money, which it already does. WSJ said these pharmaceutical companies are threatening to halt the supply that it needs to give the government if it does not pay more to the original agreement, raising its prices.
Read Also : COVID-19 Swab Tests Raises DNA Privacy Concerns After CDC Admits 10% Goes To Genome Lab!
COVID-19 Pills: Limited Access to Public?
Pfizer's Paxlovid and Merck's Molnupiravir are the world's earliest COVID-19 pills, with some aiming to also bring their concoctions for the public to use. However, the threats to stopping the deliveries and manufacturing, asking for more money.
It may mean that public access to the drug will be limited, especially as its distribution has a chokepoint.
COVID-19 Pills Now
They say vaccines are better than cures, but what can a person do if they get infected by the virus despite their immunization against it? What more do those that get infected by the virus and have no vaccines or protection against COVID-19, which is one of the most infectious viruses of all time?
The answer to those questions is the COVID-19 pill that will bring healing to the public and help them recover from the virus in its incubation time in the body. Pfizer and Merck are the two companies that focused on bringing the COVID pill, with the former claiming that it will prevent hospitalization and death by 89 percent.
On the other hand, Merck's "Molnupiravir" also received high praises from the UK region, especially with its "game-changing" effects on a person that feels the flu-like symptoms of COVID. The pill helps greatly against the flu and COVID-19, being two almost similar viruses in the industry now, being pioneers in the game.
COVID Pills are here as a last resort when getting infected by the corona, helping the public heal from the virus, but its accessibility may be an issue soon.
Related Article : COVID-19 Face Mask's Titanium Dioxide Particles Cause Cancer? Experts Say They Should Be Regulated
This article is owned by TechTimes
Written by Isaiah Richard
